Clinical Trial Update: 12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting 12-month efficacy and safety results of Diepalrestat in adults with diabetic peripheral neuropathy from a placebo-controlled stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Diepalrestat (Diepalrestat)

Snippet

Sponsor: NeuromaxBionevia | Conditions: Diabetic Peripheral Neuropathy | Phase 2, Phase 3 | Status: COMPLETED